HWAM
TEVA icon

Hennion & Walsh Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
327,801
-9,243
-3% -$308K 0.32% 60
2026
Q1 		$10.2M Sell
337,044
-4,941
-1% -$159K 0.34% 51
2025
Q4 		$10.7M Buy
341,985
+22,962
+7% +$566K 0.37% 47
2025
Q3 		$6.44M Sell
319,023
-202
-0.1% -$3.55K 0.23% 85
2025
Q2 		$5.35M Sell
319,225
-50,672
-14% -$818K 0.22% 101
2025
Q1 		$5.69M Sell
369,897
-1,686
-0.5% -$30.1K 0.25% 83
2024
Q4 		$8.19M Buy
371,583
+61,467
+20% +$1.12M 0.37% 48
2024
Q3 		$5.59M Buy
310,116
+20,837
+7% +$365K 0.26% 84
2024
Q2 		$4.7M Buy
289,279
+83,117
+40% +$1.28M 0.24% 93
2024
Q1 		$2.91M Buy
206,162
+47,954
+30% +$604K 0.16% 178
2023
Q4 		$1.65M Buy
158,208
+70,603
+81% +$659K 0.09% 282
2023
Q3 		$894K Buy
87,605
+40,424
+86% +$376K 0.06% 384
2023
Q2 		$355K Buy
+47,181
New +$383K 0.02% 609
2021
Q4 		– Sell
-125,913
Closed -$1.23M – 785
2021
Q3 		$1.23M Sell
125,913
-5,435
-4% -$50.9K 0.06% 312
2021
Q2 		$1.3M Buy
131,348
+303
+0.2% +$3.21K 0.07% 312
2021
Q1 		$1.51M Buy
+131,045
New +$1.5M 0.09% 277

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Hennion & Walsh Asset Management's TEVA Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 2.7% in Q2 2026, selling an estimated $308K and leaving 327,801 shares worth $11.1M. The position accounts for 0.32% of the portfolio, ranked #60.

Hennion & Walsh Asset Management first reported a position in TEVA in Q1 2021 and has held it in 16 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Hennion & Walsh Asset Management held 327,801 shares of Teva Pharmaceuticals worth $11.1M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 9,243 Teva Pharmaceuticals shares in Q2 2026, an estimated $308K.
  • Teva Pharmaceuticals made up 0.32% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #60 holding.
  • Hennion & Walsh Asset Management first reported a position in Teva Pharmaceuticals in Q1 2021 and has held it in 16 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.